Relay Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Core Insights - Relay Therapeutics, Inc. is a clinical-stage precision medicine company focused on transforming the drug discovery process through advanced computational and experimental technologies [3] - The company will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025, at 7:30 a.m. PT [1] - Relay Therapeutics aims to enhance small molecule therapeutic discovery in targeted oncology and genetic disease indications using its Dynamo® platform [3] Company Overview - Relay Therapeutics combines leading-edge computational and experimental approaches to address previously intractable protein targets in drug discovery [3] - The company is positioned at the intersection of complementary techniques and technologies, striving to push the boundaries of drug discovery [3] - More information about the company can be found on its website and social media platforms [3]